Integra LifeSciences Corporation
106
4
6
61
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
31.1%
33 terminated/withdrawn out of 106 trials
64.9%
-21.6% vs industry average
8%
8 trials in Phase 3/4
84%
51 of 61 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (106)
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
Role: lead
SurgiMend Mesh at the Hiatus
Role: collaborator
MicroMatrix® Flex in Tunneling Wounds
Role: lead
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
Role: lead
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Role: lead
External Ventricular Drainage Post-Market Clinical Follow-up Registry
Role: lead
Tissue Quality of Integra vs. BTM Treated Burns
Role: lead
AERA Pediatrics Registry
Role: lead
Intracranial PrEssure Time dOse (ImPETO)
Role: collaborator
The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)
Role: lead
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
Role: collaborator
T-GENVIH-003 LTFU (Long Term Follow Up) Study
Role: lead
Suturable DuraGen™ PMCF Study
Role: lead
The SurgiMend PRS Retrospective Study
Role: lead
Bactiseal Catheter Safety Registry Study
Role: lead
Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
Role: lead
Clinical Evaluation of the Ethmoid Sinus Spacer
Role: lead
Tympanostomy Tube Placement in Children in the Office (Inova Study)
Role: lead
Optimization and Refinement of Technique in In-Office Sinus Dilation 2
Role: lead
Evaluation of the Tympanostomy Tube Delivery System
Role: lead